What is the recommended diagnostic approach and treatment for scarring (cicatricial) alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Scarring Alopecia: Diagnostic Approach and Treatment

For suspected scarring alopecia, perform scalp examination looking specifically for loss of follicular ostia (the clinical hallmark), obtain a scalp biopsy when diagnosis is uncertain, and initiate early anti-inflammatory treatment with high-potency topical corticosteroids (class III-IV) and/or intralesional triamcinolone acetonide to prevent irreversible hair loss.

Diagnostic Approach

Clinical Examination Priority

The most critical diagnostic feature is loss of follicular ostia (hair follicle openings), which distinguishes scarring from non-scarring alopecia 1. This is your primary clinical marker.

Key examination findings to document:

  • Presence or absence of follicular ostia
  • Pattern of hair loss (central vs. diffuse vs. patchy)
  • Scalp inflammation signs: erythema, scaling, pustules, or perifollicular erythema
  • Symptoms: pruritus, burning, tenderness 2

Dermoscopy/Trichoscopy

Use dermoscopy to enhance diagnostic accuracy. Unlike alopecia areata (which shows yellow dots, exclamation mark hairs), scarring alopecias demonstrate loss of follicular openings and fibrotic changes 1.

When to Biopsy

Obtain a scalp biopsy when:

  • Clinical diagnosis is uncertain
  • Differentiating between subtypes of primary cicatricial alopecia
  • Distinguishing early scarring alopecia from non-scarring conditions 2, 1

The biopsy should include both vertical and horizontal sections for optimal histopathologic assessment 3.

Classification Framework

Primary cicatricial alopecias are classified by predominant inflammatory infiltrate 2:

  • Lymphocytic: Lichen planopilaris, frontal fibrosing alopecia, discoid lupus erythematosus, central centrifugal cicatricial alopecia
  • Neutrophilic: Folliculitis decalvans, dissecting cellulitis
  • Mixed: Mixed pattern inflammation
  • Nonspecific: Unclear inflammatory pattern

Treatment Approach

Critical Principle

Scarring alopecias are trichologic emergencies 4. Hair loss is permanent and irreversible once scarring occurs. Early aggressive treatment is essential to halt progression—do not expect hair regrowth in already scarred areas 2.

First-Line Anti-Inflammatory Therapy

Initiate immediately upon diagnosis:

  • High-potency topical corticosteroids (class III-IV): Apply to affected areas daily 2
  • Intralesional triamcinolone acetonide: Inject into active inflammatory areas 2, 5

These treatments apply across most primary cicatricial alopecia subtypes regardless of inflammatory pattern.

Systemic Therapy Selection

Choose based on predominant inflammatory infiltrate and disease severity 2:

For lymphocytic patterns (LPP, FFA, DLE):

  • Hydroxychloroquine for lupus-related cases
  • Oral corticosteroids for acute flares
  • Immunomodulators (mycophenolate mofetil, methotrexate) for refractory cases

For neutrophilic patterns (folliculitis decalvans):

  • Oral antibiotics with anti-inflammatory properties (doxycycline, rifampin combinations)
  • Isotretinoin for severe cases

For central centrifugal cicatricial alopecia:

  • Consider screening for thyroid disease and diabetes 6
  • Patients using metformin showed better outcomes 6

Treatment Goals

Your objectives are to 2:

  1. Stop or delay hair loss progression
  2. Reduce clinical inflammation
  3. Alleviate symptoms (pain, pruritus, burning)
  4. NOT to regrow hair in scarred areas (set realistic expectations)

Critical Prognostic Factors

Worse outcomes associated with:

  • Presence of scaling or pustules at presentation 6
  • History of thyroid disease 6
  • Delayed diagnosis and treatment initiation 4

Better outcomes associated with:

  • Natural hairstyles (avoiding traction) 6
  • Absence of concurrent thyroid disease 6
  • Early intervention before extensive scarring 4

Common Pitfalls to Avoid

  1. Delaying biopsy in uncertain cases: Diagnosis is often delayed because early disease can be subclinical 2. When in doubt, biopsy.

  2. Promising hair regrowth: Once follicles are destroyed and replaced by fibrous tissue, regrowth is impossible. Set realistic expectations from the start 2.

  3. Underestimating psychological impact: Scarring alopecia causes tremendous anxiety and psychosocial stress 4. Offer psychological support and camouflage techniques 2.

  4. Missing systemic associations: Screen for associated conditions, particularly in central centrifugal cicatricial alopecia (thyroid disease, diabetes, uterine fibroids) 6, 7.

  5. Waiting for "definitive" diagnosis before treating: If clinical examination strongly suggests active scarring alopecia, initiate anti-inflammatory treatment while awaiting biopsy results to prevent further irreversible damage.

References

Research

Cicatricial alopecia.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2018

Research

Scarring alopecias: a trichologic emergency.

Seminars in cutaneous medicine and surgery, 2015

Research

Treatment modalities for lymphocytic and neutrophilic scarring alopecia.

Journal of the American Academy of Dermatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.